Monitoring the higher low at .12 with NVLX
We've been reporting on the stock in recent newsletters from .11.....Could be poising for another breakout....
NVLX has seen recent inching from .10 to .14, but really hasn't gone biserk like the rest (look at PHOT for example)....Yet the news has been quite bullish for this little mmj play......In addition, the stock is in phase III trials with another drug.....last summer if flew from under 5 to .20s...has been basing near .10 for quite some time.....
Nuvilex, Inc. (NVLX)
-OTC Markets0.14 
Headlines
- Nuvilex Making Great Strides in Medical Marijuana InitiativesAccesswire(Mon 9:30AM EST)
- Nuvilex Growing Medical Marijuana Sciences to Lead Marijuana Research IndustryMarketwired(Thu, Jan 9)
- Nuvilex's Medical Marijuana Sciences Ready to Welcome New York State's Approval of the DrugMarketwired(Tue, Jan 7)
- Nuvilex, Inc. Subsidiary Medical Marijuana Sciences, Inc. Appoints University of Northern Colorado Professor, Richard M. Hyslop, Ph.D., to Scientific Advisory BoardGlobeNewswire(Mon, Jan 6)
- Nuvilex's Medical Marijuana Subsidiary Poised for Growth in the New YearMarketwired(Fri, Jan 3)
- Dr. Mark L. Rabe Develops Charter for Scientific Advisory Board of Nuvilex's Subsidiary, Medical Marijuana Sciences, Inc.GlobeNewswire(Mon, Dec 30)
- Nuvilex Lands Leading Figure in Medical Marijuana Field as Chairman of Subsidiary's Scientific Advisory BoardMarketwired(Mon, Dec 23)
- NUVILEX, INC. FinancialsEDGAR Online Financials(Sat, Dec 21)
- Nuvilex Readies for Late-Stage Trials as NCI Seeks New Pancreatic Cancer DrugsAccesswire(Fri, Dec 20)
BMIX deserves a look under .10...Saw a recent pickup from .07 to .11 or so on news below....What we find interesting here is quite strong revenue growth (83%)
No comments:
Post a Comment